Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and R... by Catherine C. Fahey, Sean Clark-Garvey, Sima Porten, Ashish M. Kamat, Thomas W. Flaig, John A. Taylor, William Y. Kim, Matthew I. Milowsky

Get full text

Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape by Patrick J. Hensley, Niyati Lobo, Kelly K. Bree, Wei Shen Tan, Paolo Gontero, Stephen B. Williams, Charles C. Guo, Gianluca Giannarini, Lars Dyrskjøt, Ashish M. Kamat

Get full text

Systematic Review and Meta-Analysis of Response Rates in BCG-unresponsive Non–Muscle-Invasive Bladder Cancer: a Consensus Statement From the International Bladder Cancer Group by Kyle M. Rose, Herney A. Garcia-Perdomo, Trinity J. Bivalacqua, Alfred Witjes, Joan Palou, Peter C. Black, Gary D. Steinberg, Seth P. Lerner, Sima P. Porten, Ashish M. Kamat, Roger Li

Get full text

Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract by Mohammad Jad Moussa, Georges C. Tabet, Arlene O. Siefker‐Radtke, Lianchun Xiao, Nathaniel R. Wilson, Jianjun Gao, Christopher J. Logothetis, Petros Grivas, Byron Lee, Amishi Y. Shah, Pavlos Msaouel, Roger Li, Leticia Campos Clemente, Jianping Zhao, Nizar M. Tannir, Ashish M. Kamat, Donna E. Hansel, Charles C. Guo, Matthew T. Campbell, Omar Alhalabi

Get full text